Tie2 Antibody

About the Target

Tie2, a tyrosine-protein kinase receptor predominantly found on vascular endothelial cells, is critical for maintaining vascular system stability. In humans, Tie2 interacts with three known ligands: angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), and angiopoietin-4 (Ang4), all of which bind Tie2 with similar affinity. Ang1 activates Tie2 by stimulating its kinase activity, whereas Ang2 primarily acts as an antagonist to Ang1, though it can function as a partial agonist in certain contexts. Depending on the literature source, TIE2 may also be discussed as CD202b and TEK.

Reported cellular context includes cell junction, cell membrane, cytoplasm, and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following TIE2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

TIE2 is commonly interpreted in the context of cardiovascular, angiogenesis, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cell membrane, and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell junction, cell membrane, and cytoplasm across matched conditions
• changes linked to vascular, contractile, or hemodynamic cell-state cues
• differences related to endothelial activation, vessel remodeling, or growth-factor exposure
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for TIE2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in TIE2 reflect biology rather than handling. When interpreting TIE2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep TIE2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.